Business scope: One of the leading Czech providers in aesthetic care, dermatology, and preventive medicine.
Fund: ESPIRA Fund I
Investment type: Acquisition of majority stake
Acquired: February 2022
“I look forward to embarking on the next chapter of sustainable development while leveraging ESPIRA’s experience, broad network and strong financial expertise. We see expansion opportunities in the market and ESPIRA can support us realising such new strategic initiatives.”